New Frontiers in Medicine

Driven by the Regulatory Genome

While most medicines target proteins, the true control system of the disease causality and cell’s regulatory networks lies within the 98% of the genome that doesn’t code for proteins.

This is the regulatory genome: the instruction layer that governs cell identity, behavior, and fate.

HAYA’s Regulatory Genome Engine

Building the Most Comprehensive Atlas to Decode Disease and Reprogram Cell States

A causally-informative atlas of the regulatory genome to transform how complex diseases are understood and treated

We generate deep, multimodal biological insight.

Through high-resolution functional genomics integrating transcriptomics, epigenomics, chromatin accessibility, and long-read sequencing, we uncover the regulatory logic that governs pathological cell states leveraging disease-relevant models and patient data from the start.

We integrate proprietary causal intelligence.

Our platform combines deep biology with a stack of advanced computational algorithms to power the HAYAtlas^TM. This unified, scalable engine links non-coding RNAs to complex disease causality and predicts their potential to reprogram cell fate, enabling us to nominate mechanistically grounded targets with unprecedented speed and precision.

This is where data becomes knowledge

Causal Insight. Predictive Power. RNA Medicines with Impact.

HAYAtlas^TM enables the identification of causal RNA-guided targets, design of programmable RNA-medicines, and translation through integrated biomarker discovery. By mapping the regulatory genome with causal clarity, we unlock and accelerate new class of RNA-guided therapies that act on the molecular origin of complex disease to restore health.

Where causal biology…

…becomes medicine